March NCSO/Price Concessions update

Drug Tariff book featured image

THIS CONTENT HAS NOW EXPIRED

March NCSO/Price Concessions update

March 18, 2016

The Department of Health granted the following price concessions for March 2016:

The price concession only applies to the month that it is granted.

Drug Pack size Price concession
Bumetanide 1mg tablets (new) 28 £2.50
Celiprolol 200mg tablets     28 £19.83
Celiprolol 400mg tablets  28 £39.65
Cimetidine 400mg tablets  60 £19.99
Clindamycin 150mg capsules  24 £12.49
Desmopressin 10micrograms/dose nasal spray (new) 60 dose £25.02
Ferrous Sulfate 200mg tablets  28 £2.85
Flecainide 50mg tablets (new) 60 £5.61
Flecainide 100mg tablets (new) 60 £5.88
Lamotrigine 5mg dispersible tablets sugar free 28 £7.99
Lercanidipine 10mg tablets  28 £5.99
Lercandipine 20mg tablets  28 £9.85
Mefenamic acid 500mg tablets 28 £10.25
Pioglitazone 15mg tablets (new) 28 £24.00
Pioglitazone 30mg tablets  28 £34.99
Pioglitazone 45mg tablets  28 £39.55
Procyclidine 5mg tablets  28 £14.00

No additional endorsements are required for price concessions.

Please note that PSNC cannot provide details of generic products that are suspected of being affected by generic supply problems unless and until the Department of Health grants a concession.

Contractors will be alerted to any updates through our website and via our e-news email.  If you wish to subscribe to our email list, you can receive an email as soon as any announcements are made.

If you have problems obtaining a Part VIII product or problems obtaining the product at the set Drug Tariff price, please report the issue to PSNC using the online feedback form on the PSNC Website.

If you have been able to source the product, please provide full details of the supplier and price paid. PSNC will investigate the extent of the problem and if appropriate discuss the issue with the Department of Health. 

Any further concessions will be posted here on the website.



Posted in:


More Latest News >

Changes to Part VIIIB

Deletions The following products have been deleted from Part VIIIB (specials and imported unlicensed medicines) of the Drug Tariff as...

Health & Care Review

Keeping up with all the latest developments in health and care policy could almost be a full time job and...

EPS nomination – core principles

This briefing provides pharmacy teams with information about the core principles of Electronic Prescription Service (EPS) Nomination. PSNC Briefing 034/16:...

July CPN is now online

The July edition of PSNC’s Community Pharmacy News is now available. This month’s CPN features: Pharmacy gains third party support...